Table 2. Laboratory findings in enrolled study participant’s#.
| Parameters | ‘Definite’ ATB (n = 2) | ‘Probable’ ATB (n = 16) | ‘Possible’ ATB (n = 13) | ‘ATB’ group$ (n = 31) | ‘Non-TB group’ (n = 34) | p-value* |
|---|---|---|---|---|---|---|
| Haemoglobin (g/dL) | 7.8 (6.1–9.6) | 9 (8–11.3) | 9.2 (5.2–10.9) | 9.1 (6.7–10.9) | 8.2 (7.3–10.3) | 0.994 |
| TLC | 9900 (9800–10000) | 7200 (5600–9700) | 9900 (6800–13000) | 8100 (6150–11725) | 11000 (8000–14600) | 0.078 |
| ESR (mm/hr) | 22 (10–34) | 27 (15.5–42.5) | 17 (12.7–24.7) | 22 (14–33.5) | 21 (12–34) | 0.604 |
| Direct bilirubin (mg/dL) | 0.3 (0.2–0.4) | 0.5 (0.3–0.7) | 0.5 (0.3–2.2) | 0.4 (0.3–0.8) | 1.3 (0.2–2.2) | 0.158 |
| Indirect bilirubin (mg/dL) | 0.55 (0.4–0.7) | 0.5 (0.4–0.7) | 0.6 (0.6–2.0) | 0.6 (0.4–0.9) | 1.3 (0.4–2.4) | 0.086 |
| AST (U/L) | 298 (44–551) | 47.5 (37–51.5) | 48 (32.7–151) | 47.5 (34.2–124.2) | 62 (45–109) | 0.581 |
| ALT (U/L) | 88.5 (31–146) | 36 (25–43) | 47 (36–125.5) | 42 (28–89) | 46.5 (28–73) | 0.978 |
| ALP (U/L) | 193 (184–201) | 165 (111–193) | 134 (119–312) | 140 (113–201) | 135 (96–200) | 0.366 |
| Urea (mg/dL) | 49.5 (43–56) | 36.5 (27.2–41) | 51 (36–84) | 41 (34–56) | 66 (41–117) | 0.013 |
| Creatinine (mg/dL) | 1 (0.9–1.1) | 0.8 (0.7–1.0) | 1.2 (0.9–1.6) | 0.9 (0.8–1.2) | 1.3 (0.9–2.4) | 0.026 |
| Serum albumin (g/dL) | 2.7 (2.4–3.1) | 3 (2.3–3.4) | 2.5 (2–2.6) | 2.6 (2.3–3.0) | 2.4 (2–2.7) | 0.083 |
| Serum globulin (g/dL) | 4.2 (4.1–4.3) | 3.1 (2.4–3.7) | 3.5 (2.8–3.7) | 3.4 (2.5–3.9) | 3.6 (3.3–4.3) | 0.067 |
| AF Cytology (cu. mm) | 175 (150–200) | 250 (90–350) | 200 (150–600) | 200 (150–350) | 100 (50–275) | 0.154 |
| AF Sugar (mg/dL) | 141 (78–205) | 90 (76–97) | 99 (61–109.5) | 93 (73.2–104) | 108 (84–142) | 0.030 |
| AF Protein (g/dL) | 1 (0.8–1.2) | 3.9 (2.9–5.0) | 2.2 (1.9–2.9) | 2.9 (2.1–4.2) | 1.8 (1.1–2.7) | 0.027 |
| Blood sugar (mg/dL) | NA | 78 (71.5–113) | 112 (86–137) | 90 (73–126) | 102 (83–140) | 0.260 |
| SAAG’s Ratio (g/dL) | 2.0 (1.9–2.2) | 0.9 (0.5–1) | 1.3 (1–1.6) | 1.0 (0.7–1.6) | 1.7 (1.3–1.9) | 0.003 |
| ADA (U/L) | 38.9 (12–65.8) | 41 (28–46.7) | 28.0 (11.1–32.8) | 33.3 (12.2–41.6) | 7.7 (4.6–10.4) | 0.001 |
| Uric acid (mg/dL) | 7.2 (3.3–11.1) | 6.0 (4–9) | 4.7 (3.2–6.6) | 5.9 (3.3–8.8) | 7.0 (6–9.5) | 0.047 |
#Values indicated as median of the laboratory findings in each category; numbers in brackets denotes the 1st and 3rd quartile values [except in Definite ATB group (n = 2), where it denotes range].
$ATB group includes ‘Definite’, ‘Probable’ and ‘Possible’ ATB categories collectively.
*statistical significance calculated between ‘ATB’ group vs. ‘Non-TB group using Mann Whitney’s test, significant values (p-value < 0.05) are in bold. NA- data not available. TLC- total leucocyte count, ESR- erythrocyte sedimentation rate, AST- Aspartate amino transferase, ALT- Alanine amino transferase, ALP- Alkaline phosphatase, AF- ascitic fluid, SAAG’s ratio- serum ascites albumin gradient ratio, ADA- adenosine deaminase assay.